Navigation Links
BASF Officially Launches the Collaborative Advanced Research Initiative at Harvard University
Date:4/29/2008

- Opening celebrated with inaugural Symposium on Biofilms

CAMBRIDGE, Mass. and LUDWIGSHAFEN, Germany, April 29 /PRNewswire/ -- BASF today announced the official launch of the BASF Advanced Research Initiative at Harvard University. The Advanced Research Initiative at Harvard University represents an innovative model for university-industry collaboration designed specifically to drive new frontiers of scientific discovery. The opening of the initiative was celebrated with an inaugural two-day Symposium on Biofilms held in Cambridge, Massachusetts.

The decisive difference of this collaboration between academia and industry from most research initiatives is its more integrative nature: BASF researchers from Germany are working closely with Harvard academic research teams, easing scientific exchange on the projects, as well as fostering broader interaction between the two institutions. This arrangement also gives the students the opportunity to benefit from a close interaction and early exposure to industry. Harvard faculty will also have the freedom to distribute and publish findings from the initiative, and BASF will have the opportunity to further develop discoveries and innovations for possible commercialization.

Since the BASF Advanced Research Initiative at Harvard University was first announced last fall, 10 postdoctoral students from the United States, France, Italy, Switzerland and China have already started working in Harvard labs on multiple projects. For example, they are studying the interaction between bacteria and surfaces under various conditions and developing new types of surfaces in order to uncover structure-property relationships with respect to the interaction. Another project involves the use of colloidal techniques to develop formulations of pharmaceutical actives with a higher bioavailability. Over the next five years, with direct funding from BASF to reach up to $20 million, the students will pursue further proj
'/>"/>

SOURCE BASF Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. The COSHAR Foundation Launches National Childhood Immunization Awareness Campaign During National Infant Immunization Week (April 19-26)
2. CardioMind Launches First-in-Human Trial of Small Vessel, Drug-Eluting Stent
3. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
4. Focus Diagnostics Launches Laboratory Test for Chikungunya Virus
5. deCODE Launches a DNA-Based Test for Assessing Risk of Prostate Cancer on the Back of the Discovery of New Prostate Cancer Genes
6. Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics
7. Siemens Healthcare Diagnostics Launches B12, Folate, and Ferritin Tests on Its Dimension vista Intelligent Lab System
8. Hospital Launches Landmark Emergency Medicine Project
9. Watson Launches Generic Biaxin(R) XL
10. Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder
11. APIC Launches Targeting Zero Initiative to Eradicate C. Difficile and Infections Deemed Preventable By CMS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)DURHAM, N.C., Dec. 4 Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today announced that the first patient has been enrolled in the company,s Phase II-b, dose escalation, clinical trial in S
(Date:12/4/2009)WASHINGTON, Dec. 4 Chemistry World recently highlighted a new report published by the Pharmaceutical Research and Manufacturers of America ( PhRMA ) that identifies 97 new drugs and vaccines in
(Date:12/4/2009)SAN DIEGO, Calif., Dec. 4 Suneva Medical, a privately-held aesthetic medical device company, today announced the appointment of Philip Ranker as Vice President and Chief Financial Officer. In this r
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4FDA to Study Ways to Be More Open With Public 47702 1FDA to Study Ways to Be More Open With Public 47702 2FDA to Study Ways to Be More Open With Public 47702 3TV Interferes With Infants Language Development 47700 1TV Interferes With Infants Language Development 47700 2Florida Hospital Cardiovascular Institute Completes House Wide Implementation of the LifeSync 28R 29 Wireless ECG System 47699 1Florida Hospital Cardiovascular Institute Completes House Wide Implementation of the LifeSync 28R 29 Wireless ECG System 47699 2Florida Hospital Cardiovascular Institute Completes House Wide Implementation of the LifeSync 28R 29 Wireless ECG System 47699 3
...dults can improve memory and attention by training...y data presented today at the annual meeting of th...h Zelinski, PhD, lead investigator on the study an...ornia , also reported on new data showing that the... , A total of 487 healthy adults over the age of 6...
...g a steroid drug for multiple sclerosis (MS) in ad...ase activity more than using the MS drug alone, ac...reaking Science Program at the American Academy of... 25 - May 2, 2009. , , For the study, people wi... in monthly "pulses," or three doses over three da...
Other Medicine Technology:Brain Training Improves Memory and Attention and the Effects Last 2Adding Steroid Drug to MS Treatment May Reduce Disease Activity 2
(Date:12/5/2009)NEW ORLEANS, Dec. 5 There have been significant scientific advances in the field of blood cancers, and leading experts continue to gain a better understanding of how certain diseases progress in orde
(Date:12/5/2009)NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative disorders are serious and often deadly blood cancers. Research presented today at the 51st Annual Meeting of the American Society of Hematology int
(Date:12/5/2009)AVIVA today announced the launch of International Solutions, an innovative new international private medical insurance plan which follows the acclaimed modular design of its UK equivalent. In addition
(Date:12/4/2009)NEW YORK, Dec. 4 Care Investment Trust Inc. (NYSE: CRE ) ("Care" or the "Company") today announced that its Board of Directors has declared a dividend of $0.17 per share of common stock. The div
(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i
Breaking Medicine News(10 mins):Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2
... PHILADELPHIA Researchers from the Abramson Canc...ced today that findings from two large, internatio...r patients with multiple myeloma, a cancer that oc...methasone, patients significantly improved by all ...
...elebrity Fit Club expert/best-selling author Dr. I...tive to Big Easy; Urges residents to give up,pound... Full Gospel Baptist ...and give up the pounds to fight the epidemic of ex...
...EW YORK, Nov. 21 Flagship Global Health,Inc. ("Fl...promotion of,John Flood as its new Chief Executive...f the Board of Flagship. Mr. Flood has been Presid...m will,focus on the strategic direction of the Com...
... new program counters idea that seniors are by nat...) -- Many older adults may mistakenly believe that...ng, but a new pilot program suggests it,s easy to ...to the leaders of a University of California, Los ...
... thalidomide derivative plus dexamethasone improve...ov. 21 (HealthDay News) -- A combination drug regi...nded survival, as well as the time it took for the...dministration regulatory approval in June of 2006 ...
...DMONTON, Alberta, Nov. 21 What would you do if yo...Tommy Beel ate properly,never smoked, wasn,t a dri...p each night. At the young age of 32, he suffered ...com ), Beel shares his,experiences of being strick...
Other Medicine News:Health News:Penn's Abramson Cancer Center part of major phase III study for myeloma 2Health News:Penn's Abramson Cancer Center part of major phase III study for myeloma 3Health News:Challenge Tops 1,040,000 lbs, National Tour Makes 14th Stop in New Orleans for Bayou Classic 2Health News:Challenge Tops 1,040,000 lbs, National Tour Makes 14th Stop in New Orleans for Bayou Classic 3Health News:Challenge Tops 1,040,000 lbs, National Tour Makes 14th Stop in New Orleans for Bayou Classic 4Health News:John H. Flood III Named as CEO of Flagship Global Health, Inc. 2Health News:Aging Isn't About Slowing Down, Experts Say 2Health News:Drug Combo Boosts Multiple Myeloma Survival 2Health News:Drug Combo Boosts Multiple Myeloma Survival 3Health News:The Blessing of a Brain Injury: Author Survives Injury to Brain Following Stroke, Uses Injury as Fuel to Overcome Odds 2
View Mex-3 Portable Xenon Headlight
Light-Tech Model 585T
Light-Tech Model 565
Xenon Surgical Headlight System
Medicine Products: